nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—ABCG2—Vemurafenib—melanoma	0.15	0.207	CbGbCtD
Zafirlukast—ABCG2—Dactinomycin—melanoma	0.0996	0.138	CbGbCtD
Zafirlukast—CYP2E1—Dacarbazine—melanoma	0.0819	0.113	CbGbCtD
Zafirlukast—CYP1A2—Carmustine—melanoma	0.0782	0.108	CbGbCtD
Zafirlukast—CYP1A2—Vemurafenib—melanoma	0.0618	0.0854	CbGbCtD
Zafirlukast—CYP3A4—Temozolomide—melanoma	0.0591	0.0817	CbGbCtD
Zafirlukast—ABCG2—Docetaxel—melanoma	0.0515	0.0711	CbGbCtD
Zafirlukast—CYP2D6—Vemurafenib—melanoma	0.0509	0.0704	CbGbCtD
Zafirlukast—CYP1A2—Dacarbazine—melanoma	0.0474	0.0655	CbGbCtD
Zafirlukast—CYP3A4—Vemurafenib—melanoma	0.0324	0.0447	CbGbCtD
Zafirlukast—CYP3A4—Docetaxel—melanoma	0.0111	0.0154	CbGbCtD
Zafirlukast—Traumatic liver injury—Temozolomide—melanoma	0.00361	0.028	CcSEcCtD
Zafirlukast—Hepatotoxicity—Vemurafenib—melanoma	0.00341	0.0264	CcSEcCtD
Zafirlukast—Raised liver function tests—Dactinomycin—melanoma	0.00322	0.025	CcSEcCtD
Zafirlukast—Vasculitis—Vemurafenib—melanoma	0.0027	0.0209	CcSEcCtD
Zafirlukast—Digestion impaired—Temozolomide—melanoma	0.00201	0.0156	CcSEcCtD
Zafirlukast—Raised liver function tests—Docetaxel—melanoma	0.00194	0.015	CcSEcCtD
Zafirlukast—Hepatotoxicity—Dactinomycin—melanoma	0.00193	0.0149	CcSEcCtD
Zafirlukast—Hepatotoxicity—Carmustine—melanoma	0.0018	0.014	CcSEcCtD
Zafirlukast—Hepatotoxicity—Temozolomide—melanoma	0.00174	0.0135	CcSEcCtD
Zafirlukast—Eosinophilia—Vemurafenib—melanoma	0.00164	0.0127	CcSEcCtD
Zafirlukast—Liver injury—Temozolomide—melanoma	0.0016	0.0124	CcSEcCtD
Zafirlukast—Accidental injury—Carmustine—melanoma	0.00157	0.0122	CcSEcCtD
Zafirlukast—Glyburide—SLC15A2—melanoma	0.00157	0.476	CrCbGaD
Zafirlukast—Hyperbilirubinaemia—Temozolomide—melanoma	0.00148	0.0115	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Vemurafenib—melanoma	0.00144	0.0112	CcSEcCtD
Zafirlukast—Neuropathy—Carmustine—melanoma	0.00131	0.0101	CcSEcCtD
Zafirlukast—Influenza like illness—Temozolomide—melanoma	0.00131	0.0101	CcSEcCtD
Zafirlukast—Neuropathy—Temozolomide—melanoma	0.00126	0.00979	CcSEcCtD
Zafirlukast—Injury—Bleomycin—melanoma	0.00126	0.00976	CcSEcCtD
Zafirlukast—Throat sore—Docetaxel—melanoma	0.00124	0.00962	CcSEcCtD
Zafirlukast—Oropharyngeal discomfort—Docetaxel—melanoma	0.00123	0.00953	CcSEcCtD
Zafirlukast—Hepatic failure—Dactinomycin—melanoma	0.0012	0.00931	CcSEcCtD
Zafirlukast—Hepatotoxicity—Docetaxel—melanoma	0.00116	0.00898	CcSEcCtD
Zafirlukast—Swelling—Carmustine—melanoma	0.00115	0.00888	CcSEcCtD
Zafirlukast—Back pain—Vemurafenib—melanoma	0.00111	0.00862	CcSEcCtD
Zafirlukast—Injury—Carmustine—melanoma	0.0011	0.00852	CcSEcCtD
Zafirlukast—Hepatic failure—Temozolomide—melanoma	0.00109	0.00842	CcSEcCtD
Zafirlukast—Tolvaptan—ABCB1—melanoma	0.00107	0.324	CrCbGaD
Zafirlukast—Liver function test abnormal—Dactinomycin—melanoma	0.000997	0.00772	CcSEcCtD
Zafirlukast—Oropharyngeal pain—Docetaxel—melanoma	0.000984	0.00762	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Docetaxel—melanoma	0.000984	0.00762	CcSEcCtD
Zafirlukast—Arthralgia—Vemurafenib—melanoma	0.00098	0.00759	CcSEcCtD
Zafirlukast—Myalgia—Vemurafenib—melanoma	0.00098	0.00759	CcSEcCtD
Zafirlukast—Infection—Vemurafenib—melanoma	0.000933	0.00723	CcSEcCtD
Zafirlukast—Liver function test abnormal—Carmustine—melanoma	0.000933	0.00723	CcSEcCtD
Zafirlukast—Neutropenia—Dactinomycin—melanoma	0.000873	0.00676	CcSEcCtD
Zafirlukast—Influenza like illness—Docetaxel—melanoma	0.000869	0.00673	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000856	0.00663	CcSEcCtD
Zafirlukast—Neuropathy—Docetaxel—melanoma	0.00084	0.00651	CcSEcCtD
Zafirlukast—Neutropenia—Carmustine—melanoma	0.000817	0.00633	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Vemurafenib—melanoma	0.000811	0.00628	CcSEcCtD
Zafirlukast—Fatigue—Vemurafenib—melanoma	0.00081	0.00627	CcSEcCtD
Zafirlukast—Haemoglobin—Bleomycin—melanoma	0.000805	0.00624	CcSEcCtD
Zafirlukast—Haemorrhage—Bleomycin—melanoma	0.000801	0.00621	CcSEcCtD
Zafirlukast—Hypoaesthesia—Bleomycin—melanoma	0.000797	0.00617	CcSEcCtD
Zafirlukast—Neutropenia—Temozolomide—melanoma	0.000789	0.00612	CcSEcCtD
Zafirlukast—Agranulocytosis—Dactinomycin—melanoma	0.000777	0.00602	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Carmustine—melanoma	0.000763	0.00591	CcSEcCtD
Zafirlukast—Hepatitis—Dactinomycin—melanoma	0.000747	0.00579	CcSEcCtD
Zafirlukast—Body temperature increased—Vemurafenib—melanoma	0.000742	0.00575	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Temozolomide—melanoma	0.000738	0.00572	CcSEcCtD
Zafirlukast—Swelling—Docetaxel—melanoma	0.000736	0.0057	CcSEcCtD
Zafirlukast—Hepatic failure—Docetaxel—melanoma	0.000723	0.0056	CcSEcCtD
Zafirlukast—Sinusitis—Temozolomide—melanoma	0.000706	0.00547	CcSEcCtD
Zafirlukast—Haemoglobin—Carmustine—melanoma	0.000703	0.00544	CcSEcCtD
Zafirlukast—Haemorrhage—Carmustine—melanoma	0.000699	0.00542	CcSEcCtD
Zafirlukast—Hypoaesthesia—Carmustine—melanoma	0.000696	0.00539	CcSEcCtD
Zafirlukast—Hypersensitivity—Vemurafenib—melanoma	0.000692	0.00536	CcSEcCtD
Zafirlukast—Dermatitis bullous—Docetaxel—melanoma	0.00068	0.00526	CcSEcCtD
Zafirlukast—Haemoglobin—Temozolomide—melanoma	0.000679	0.00526	CcSEcCtD
Zafirlukast—Haemorrhage—Temozolomide—melanoma	0.000676	0.00523	CcSEcCtD
Zafirlukast—Hepatitis—Temozolomide—melanoma	0.000676	0.00523	CcSEcCtD
Zafirlukast—Asthenia—Vemurafenib—melanoma	0.000674	0.00522	CcSEcCtD
Zafirlukast—Hypoaesthesia—Temozolomide—melanoma	0.000672	0.00521	CcSEcCtD
Zafirlukast—Pruritus—Vemurafenib—melanoma	0.000664	0.00515	CcSEcCtD
Zafirlukast—Ill-defined disorder—Bleomycin—melanoma	0.000647	0.00501	CcSEcCtD
Zafirlukast—Diarrhoea—Vemurafenib—melanoma	0.000643	0.00498	CcSEcCtD
Zafirlukast—Malaise—Bleomycin—melanoma	0.000629	0.00487	CcSEcCtD
Zafirlukast—Dizziness—Vemurafenib—melanoma	0.000621	0.00481	CcSEcCtD
Zafirlukast—Ill-defined disorder—Dactinomycin—melanoma	0.000603	0.00467	CcSEcCtD
Zafirlukast—Liver function test abnormal—Docetaxel—melanoma	0.0006	0.00465	CcSEcCtD
Zafirlukast—Vomiting—Vemurafenib—melanoma	0.000597	0.00463	CcSEcCtD
Zafirlukast—Myalgia—Bleomycin—melanoma	0.000594	0.0046	CcSEcCtD
Zafirlukast—Rash—Vemurafenib—melanoma	0.000592	0.00459	CcSEcCtD
Zafirlukast—Dermatitis—Vemurafenib—melanoma	0.000592	0.00458	CcSEcCtD
Zafirlukast—Back pain—Carmustine—melanoma	0.000589	0.00456	CcSEcCtD
Zafirlukast—Headache—Vemurafenib—melanoma	0.000588	0.00456	CcSEcCtD
Zafirlukast—Discomfort—Bleomycin—melanoma	0.000586	0.00454	CcSEcCtD
Zafirlukast—Malaise—Dactinomycin—melanoma	0.000586	0.00454	CcSEcCtD
Zafirlukast—Oedema—Bleomycin—melanoma	0.000569	0.00441	CcSEcCtD
Zafirlukast—Back pain—Temozolomide—melanoma	0.000569	0.00441	CcSEcCtD
Zafirlukast—Infection—Bleomycin—melanoma	0.000565	0.00438	CcSEcCtD
Zafirlukast—Nausea—Vemurafenib—melanoma	0.000558	0.00432	CcSEcCtD
Zafirlukast—Thrombocytopenia—Bleomycin—melanoma	0.000557	0.00432	CcSEcCtD
Zafirlukast—Myalgia—Dactinomycin—melanoma	0.000554	0.00429	CcSEcCtD
Zafirlukast—Discomfort—Dactinomycin—melanoma	0.000547	0.00424	CcSEcCtD
Zafirlukast—Ill-defined disorder—Temozolomide—melanoma	0.000546	0.00423	CcSEcCtD
Zafirlukast—Angioedema—Temozolomide—melanoma	0.000537	0.00416	CcSEcCtD
Zafirlukast—Oedema—Dactinomycin—melanoma	0.000531	0.00411	CcSEcCtD
Zafirlukast—Malaise—Temozolomide—melanoma	0.00053	0.00411	CcSEcCtD
Zafirlukast—Infection—Dactinomycin—melanoma	0.000527	0.00408	CcSEcCtD
Zafirlukast—Neutropenia—Docetaxel—melanoma	0.000525	0.00407	CcSEcCtD
Zafirlukast—Thrombocytopenia—Dactinomycin—melanoma	0.00052	0.00403	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Bleomycin—melanoma	0.000518	0.00402	CcSEcCtD
Zafirlukast—Myalgia—Carmustine—melanoma	0.000518	0.00401	CcSEcCtD
Zafirlukast—Arthralgia—Temozolomide—melanoma	0.000501	0.00388	CcSEcCtD
Zafirlukast—Myalgia—Temozolomide—melanoma	0.000501	0.00388	CcSEcCtD
Zafirlukast—Oedema—Carmustine—melanoma	0.000497	0.00385	CcSEcCtD
Zafirlukast—Discomfort—Temozolomide—melanoma	0.000495	0.00383	CcSEcCtD
Zafirlukast—Infection—Carmustine—melanoma	0.000493	0.00382	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Docetaxel—melanoma	0.000491	0.0038	CcSEcCtD
Zafirlukast—Jaundice—Docetaxel—melanoma	0.000488	0.00378	CcSEcCtD
Zafirlukast—Pain—Bleomycin—melanoma	0.000487	0.00377	CcSEcCtD
Zafirlukast—Thrombocytopenia—Carmustine—melanoma	0.000486	0.00377	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000484	0.00375	CcSEcCtD
Zafirlukast—Oedema—Temozolomide—melanoma	0.00048	0.00372	CcSEcCtD
Zafirlukast—Infection—Temozolomide—melanoma	0.000477	0.00369	CcSEcCtD
Zafirlukast—Thrombocytopenia—Temozolomide—melanoma	0.00047	0.00364	CcSEcCtD
Zafirlukast—Feeling abnormal—Bleomycin—melanoma	0.000469	0.00363	CcSEcCtD
Zafirlukast—Agranulocytosis—Docetaxel—melanoma	0.000467	0.00362	CcSEcCtD
Zafirlukast—Fatigue—Dactinomycin—melanoma	0.000458	0.00354	CcSEcCtD
Zafirlukast—Pain—Dactinomycin—melanoma	0.000454	0.00352	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Carmustine—melanoma	0.000453	0.00351	CcSEcCtD
Zafirlukast—Urticaria—Bleomycin—melanoma	0.000452	0.0035	CcSEcCtD
Zafirlukast—Haemoglobin—Docetaxel—melanoma	0.000452	0.0035	CcSEcCtD
Zafirlukast—Body temperature increased—Bleomycin—melanoma	0.00045	0.00349	CcSEcCtD
Zafirlukast—Hepatitis—Docetaxel—melanoma	0.000449	0.00348	CcSEcCtD
Zafirlukast—Haemorrhage—Docetaxel—melanoma	0.000449	0.00348	CcSEcCtD
Zafirlukast—Insomnia—Carmustine—melanoma	0.000449	0.00348	CcSEcCtD
Zafirlukast—Hypoaesthesia—Docetaxel—melanoma	0.000447	0.00346	CcSEcCtD
Zafirlukast—Feeling abnormal—Dactinomycin—melanoma	0.000437	0.00339	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Temozolomide—melanoma	0.000437	0.00339	CcSEcCtD
Zafirlukast—Insomnia—Temozolomide—melanoma	0.000434	0.00336	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Dactinomycin—melanoma	0.000434	0.00336	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Carmustine—melanoma	0.000429	0.00332	CcSEcCtD
Zafirlukast—Pain—Carmustine—melanoma	0.000425	0.00329	CcSEcCtD
Zafirlukast—Dyspepsia—Temozolomide—melanoma	0.000423	0.00327	CcSEcCtD
Zafirlukast—Body temperature increased—Dactinomycin—melanoma	0.00042	0.00325	CcSEcCtD
Zafirlukast—Abdominal pain—Dactinomycin—melanoma	0.00042	0.00325	CcSEcCtD
Zafirlukast—Hypersensitivity—Bleomycin—melanoma	0.000419	0.00325	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Temozolomide—melanoma	0.000414	0.00321	CcSEcCtD
Zafirlukast—Fatigue—Temozolomide—melanoma	0.000414	0.00321	CcSEcCtD
Zafirlukast—Pain—Temozolomide—melanoma	0.00041	0.00318	CcSEcCtD
Zafirlukast—Feeling abnormal—Carmustine—melanoma	0.000409	0.00317	CcSEcCtD
Zafirlukast—Asthenia—Bleomycin—melanoma	0.000408	0.00316	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Carmustine—melanoma	0.000406	0.00315	CcSEcCtD
Zafirlukast—Pruritus—Bleomycin—melanoma	0.000403	0.00312	CcSEcCtD
Zafirlukast—Feeling abnormal—Temozolomide—melanoma	0.000396	0.00306	CcSEcCtD
Zafirlukast—Body temperature increased—Carmustine—melanoma	0.000393	0.00304	CcSEcCtD
Zafirlukast—Abdominal pain—Carmustine—melanoma	0.000393	0.00304	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Temozolomide—melanoma	0.000393	0.00304	CcSEcCtD
Zafirlukast—Hypersensitivity—Dactinomycin—melanoma	0.000391	0.00303	CcSEcCtD
Zafirlukast—Urticaria—Temozolomide—melanoma	0.000381	0.00295	CcSEcCtD
Zafirlukast—Asthenia—Dactinomycin—melanoma	0.000381	0.00295	CcSEcCtD
Zafirlukast—Abdominal pain—Temozolomide—melanoma	0.000379	0.00294	CcSEcCtD
Zafirlukast—Body temperature increased—Temozolomide—melanoma	0.000379	0.00294	CcSEcCtD
Zafirlukast—Back pain—Docetaxel—melanoma	0.000378	0.00293	CcSEcCtD
Zafirlukast—Hypersensitivity—Carmustine—melanoma	0.000366	0.00284	CcSEcCtD
Zafirlukast—Diarrhoea—Dactinomycin—melanoma	0.000363	0.00281	CcSEcCtD
Zafirlukast—Vomiting—Bleomycin—melanoma	0.000362	0.0028	CcSEcCtD
Zafirlukast—Rash—Bleomycin—melanoma	0.000359	0.00278	CcSEcCtD
Zafirlukast—Dermatitis—Bleomycin—melanoma	0.000358	0.00278	CcSEcCtD
Zafirlukast—Asthenia—Carmustine—melanoma	0.000356	0.00276	CcSEcCtD
Zafirlukast—Hypersensitivity—Temozolomide—melanoma	0.000354	0.00274	CcSEcCtD
Zafirlukast—Asthenia—Temozolomide—melanoma	0.000344	0.00267	CcSEcCtD
Zafirlukast—Diarrhoea—Carmustine—melanoma	0.00034	0.00263	CcSEcCtD
Zafirlukast—Pruritus—Temozolomide—melanoma	0.00034	0.00263	CcSEcCtD
Zafirlukast—Nausea—Bleomycin—melanoma	0.000338	0.00262	CcSEcCtD
Zafirlukast—Glyburide—ALB—melanoma	0.000338	0.102	CrCbGaD
Zafirlukast—Vomiting—Dactinomycin—melanoma	0.000337	0.00261	CcSEcCtD
Zafirlukast—Rash—Dactinomycin—melanoma	0.000335	0.00259	CcSEcCtD
Zafirlukast—Arthralgia—Docetaxel—melanoma	0.000333	0.00258	CcSEcCtD
Zafirlukast—Myalgia—Docetaxel—melanoma	0.000333	0.00258	CcSEcCtD
Zafirlukast—Dizziness—Carmustine—melanoma	0.000328	0.00254	CcSEcCtD
Zafirlukast—Diarrhoea—Temozolomide—melanoma	0.000328	0.00254	CcSEcCtD
Zafirlukast—Glyburide—ABCB1—melanoma	0.000322	0.0977	CrCbGaD
Zafirlukast—Oedema—Docetaxel—melanoma	0.000319	0.00247	CcSEcCtD
Zafirlukast—Dizziness—Temozolomide—melanoma	0.000317	0.00246	CcSEcCtD
Zafirlukast—Infection—Docetaxel—melanoma	0.000317	0.00246	CcSEcCtD
Zafirlukast—Vomiting—Carmustine—melanoma	0.000316	0.00245	CcSEcCtD
Zafirlukast—Nausea—Dactinomycin—melanoma	0.000315	0.00244	CcSEcCtD
Zafirlukast—Rash—Carmustine—melanoma	0.000313	0.00243	CcSEcCtD
Zafirlukast—Dermatitis—Carmustine—melanoma	0.000313	0.00242	CcSEcCtD
Zafirlukast—Thrombocytopenia—Docetaxel—melanoma	0.000313	0.00242	CcSEcCtD
Zafirlukast—Headache—Carmustine—melanoma	0.000311	0.00241	CcSEcCtD
Zafirlukast—Vomiting—Temozolomide—melanoma	0.000305	0.00236	CcSEcCtD
Zafirlukast—Rash—Temozolomide—melanoma	0.000303	0.00234	CcSEcCtD
Zafirlukast—Dermatitis—Temozolomide—melanoma	0.000302	0.00234	CcSEcCtD
Zafirlukast—Headache—Temozolomide—melanoma	0.000301	0.00233	CcSEcCtD
Zafirlukast—Nausea—Carmustine—melanoma	0.000295	0.00229	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Docetaxel—melanoma	0.000291	0.00225	CcSEcCtD
Zafirlukast—Insomnia—Docetaxel—melanoma	0.000289	0.00224	CcSEcCtD
Zafirlukast—Nausea—Temozolomide—melanoma	0.000285	0.00221	CcSEcCtD
Zafirlukast—Dyspepsia—Docetaxel—melanoma	0.000281	0.00218	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Docetaxel—melanoma	0.000276	0.00214	CcSEcCtD
Zafirlukast—Fatigue—Docetaxel—melanoma	0.000275	0.00213	CcSEcCtD
Zafirlukast—Pain—Docetaxel—melanoma	0.000273	0.00211	CcSEcCtD
Zafirlukast—Feeling abnormal—Docetaxel—melanoma	0.000263	0.00204	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Docetaxel—melanoma	0.000261	0.00202	CcSEcCtD
Zafirlukast—Body temperature increased—Docetaxel—melanoma	0.000252	0.00195	CcSEcCtD
Zafirlukast—Abdominal pain—Docetaxel—melanoma	0.000252	0.00195	CcSEcCtD
Zafirlukast—Hypersensitivity—Docetaxel—melanoma	0.000235	0.00182	CcSEcCtD
Zafirlukast—Asthenia—Docetaxel—melanoma	0.000229	0.00177	CcSEcCtD
Zafirlukast—Pruritus—Docetaxel—melanoma	0.000226	0.00175	CcSEcCtD
Zafirlukast—Diarrhoea—Docetaxel—melanoma	0.000218	0.00169	CcSEcCtD
Zafirlukast—Dizziness—Docetaxel—melanoma	0.000211	0.00164	CcSEcCtD
Zafirlukast—Vomiting—Docetaxel—melanoma	0.000203	0.00157	CcSEcCtD
Zafirlukast—Rash—Docetaxel—melanoma	0.000201	0.00156	CcSEcCtD
Zafirlukast—Dermatitis—Docetaxel—melanoma	0.000201	0.00156	CcSEcCtD
Zafirlukast—Headache—Docetaxel—melanoma	0.0002	0.00155	CcSEcCtD
Zafirlukast—Nausea—Docetaxel—melanoma	0.00019	0.00147	CcSEcCtD
Zafirlukast—CYP2C9—Metabolism—BSG—melanoma	1.71e-05	0.000119	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CSPG4—melanoma	1.71e-05	0.000119	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CYP1B1—melanoma	1.71e-05	0.000119	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PIK3CA—melanoma	1.7e-05	0.000118	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MMP9—melanoma	1.68e-05	0.000117	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CDKN1A—melanoma	1.67e-05	0.000116	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PTEN—melanoma	1.67e-05	0.000116	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GPAM—melanoma	1.67e-05	0.000116	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NFKB1—melanoma	1.66e-05	0.000116	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GPAM—melanoma	1.65e-05	0.000115	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TP53—melanoma	1.64e-05	0.000114	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—AKT1—melanoma	1.63e-05	0.000113	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HRAS—melanoma	1.57e-05	0.000109	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PHGDH—melanoma	1.57e-05	0.000109	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—LUM—melanoma	1.57e-05	0.000109	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—VCAN—melanoma	1.55e-05	0.000108	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PLA2G6—melanoma	1.54e-05	0.000107	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—HPSE—melanoma	1.54e-05	0.000107	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP17A1—melanoma	1.51e-05	0.000106	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CUBN—melanoma	1.51e-05	0.000105	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—VEGFA—melanoma	1.51e-05	0.000105	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.51e-05	0.000105	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL6—melanoma	1.5e-05	0.000105	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—STAT3—melanoma	1.49e-05	0.000104	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NRAS—melanoma	1.49e-05	0.000104	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PLCB4—melanoma	1.49e-05	0.000104	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.47e-05	0.000102	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ABCB1—melanoma	1.46e-05	0.000102	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SDHD—melanoma	1.46e-05	0.000102	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CSPG4—melanoma	1.46e-05	0.000102	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—BSG—melanoma	1.46e-05	0.000102	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GNA11—melanoma	1.43e-05	9.96e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MAPK3—melanoma	1.43e-05	9.93e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PLA2G6—melanoma	1.42e-05	9.88e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.42e-05	9.88e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GPAM—melanoma	1.41e-05	9.84e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PLA2G6—melanoma	1.41e-05	9.79e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ABCB1—melanoma	1.41e-05	9.79e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—FASN—melanoma	1.4e-05	9.75e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC6A11—melanoma	1.4e-05	9.73e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIP4K2A—melanoma	1.4e-05	9.73e-05	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—AKT1—melanoma	1.39e-05	9.66e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MYC—melanoma	1.39e-05	9.66e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—VCAN—melanoma	1.39e-05	9.65e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—SLC5A5—melanoma	1.38e-05	9.59e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—MTAP—melanoma	1.36e-05	9.47e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MAPK1—melanoma	1.36e-05	9.45e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—EGFR—melanoma	1.36e-05	9.45e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PRKCA—melanoma	1.35e-05	9.37e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ERCC2—melanoma	1.33e-05	9.3e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GNAQ—melanoma	1.33e-05	9.26e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CD44—melanoma	1.33e-05	9.26e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.31e-05	9.13e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP17A1—melanoma	1.31e-05	9.12e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PRKCA—melanoma	1.29e-05	9.01e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.29e-05	9e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ERCC2—melanoma	1.28e-05	8.93e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—KRAS—melanoma	1.28e-05	8.92e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP1B1—melanoma	1.28e-05	8.88e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	1.27e-05	8.88e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—VCAN—melanoma	1.27e-05	8.87e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.27e-05	8.81e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—VCAN—melanoma	1.26e-05	8.8e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GNA11—melanoma	1.24e-05	8.61e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PHGDH—melanoma	1.21e-05	8.44e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—LUM—melanoma	1.21e-05	8.44e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—FASN—melanoma	1.21e-05	8.43e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PLA2G6—melanoma	1.2e-05	8.37e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.2e-05	8.33e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—SLC5A5—melanoma	1.19e-05	8.29e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HPSE—melanoma	1.19e-05	8.27e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PIK3CA—melanoma	1.18e-05	8.2e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP17A1—melanoma	1.17e-05	8.14e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CUBN—melanoma	1.17e-05	8.12e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.15e-05	8.04e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.15e-05	8.03e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GNAQ—melanoma	1.15e-05	8.01e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CD44—melanoma	1.15e-05	8.01e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TP53—melanoma	1.14e-05	7.93e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	1.14e-05	7.93e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SDHD—melanoma	1.13e-05	7.84e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—BSG—melanoma	1.13e-05	7.84e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CSPG4—melanoma	1.13e-05	7.84e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.13e-05	7.84e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.12e-05	7.77e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GNA11—melanoma	1.1e-05	7.69e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP1B1—melanoma	1.1e-05	7.68e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GPAM—melanoma	1.09e-05	7.6e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HRAS—melanoma	1.09e-05	7.59e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—FASN—melanoma	1.08e-05	7.52e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—VCAN—melanoma	1.08e-05	7.52e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP17A1—melanoma	1.07e-05	7.49e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP17A1—melanoma	1.07e-05	7.42e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—SLC5A5—melanoma	1.06e-05	7.4e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.06e-05	7.4e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CG—melanoma	1.05e-05	7.34e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.05e-05	7.32e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ABCB1—melanoma	1.05e-05	7.31e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL6—melanoma	1.04e-05	7.26e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.04e-05	7.23e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GNAQ—melanoma	1.03e-05	7.15e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CD44—melanoma	1.03e-05	7.15e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.02e-05	7.12e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PPARG—melanoma	1.02e-05	7.09e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GNA11—melanoma	1.02e-05	7.07e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CG—melanoma	1.01e-05	7.05e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GNA11—melanoma	1.01e-05	7.01e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1e-05	7e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.96e-06	6.93e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—FASN—melanoma	9.93e-06	6.92e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.86e-06	6.87e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—FASN—melanoma	9.85e-06	6.86e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP1B1—melanoma	9.84e-06	6.85e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PPARG—melanoma	9.78e-06	6.81e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—SLC5A5—melanoma	9.77e-06	6.81e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	9.73e-06	6.78e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—SLC5A5—melanoma	9.69e-06	6.75e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PRKCA—melanoma	9.66e-06	6.73e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AKT1—melanoma	9.62e-06	6.7e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ERCC2—melanoma	9.58e-06	6.68e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CD44—melanoma	9.44e-06	6.57e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GNAQ—melanoma	9.44e-06	6.57e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GNAQ—melanoma	9.36e-06	6.52e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CD44—melanoma	9.36e-06	6.52e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PLA2G6—melanoma	9.27e-06	6.46e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CD—melanoma	9.27e-06	6.46e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.16e-06	6.38e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ALB—melanoma	9.15e-06	6.37e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP17A1—melanoma	9.11e-06	6.34e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.08e-06	6.32e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ABCB1—melanoma	9.08e-06	6.32e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP1B1—melanoma	9.05e-06	6.3e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.98e-06	6.26e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP1B1—melanoma	8.97e-06	6.25e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CD—melanoma	8.9e-06	6.2e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	8.87e-06	6.18e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ALB—melanoma	8.79e-06	6.12e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.68e-06	6.05e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GNA11—melanoma	8.6e-06	5.99e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—FASN—melanoma	8.42e-06	5.86e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PRKCA—melanoma	8.35e-06	5.82e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—VCAN—melanoma	8.33e-06	5.8e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ERCC2—melanoma	8.28e-06	5.77e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SLC5A5—melanoma	8.28e-06	5.77e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ABCB1—melanoma	8.1e-06	5.64e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CB—melanoma	8.08e-06	5.63e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTGS2—melanoma	8e-06	5.58e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CD44—melanoma	8e-06	5.57e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GNAQ—melanoma	8e-06	5.57e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.92e-06	5.51e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.83e-06	5.45e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CB—melanoma	7.76e-06	5.41e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.76e-06	5.4e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTGS2—melanoma	7.69e-06	5.36e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP1B1—melanoma	7.67e-06	5.34e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CG—melanoma	7.57e-06	5.27e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PRKCA—melanoma	7.46e-06	5.19e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ABCB1—melanoma	7.45e-06	5.19e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ERCC2—melanoma	7.39e-06	5.15e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ABCB1—melanoma	7.39e-06	5.15e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PPARG—melanoma	7.31e-06	5.09e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP17A1—melanoma	7.03e-06	4.9e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTEN—melanoma	6.98e-06	4.86e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.86e-06	4.78e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PRKCA—melanoma	6.86e-06	4.78e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ERCC2—melanoma	6.8e-06	4.74e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PRKCA—melanoma	6.8e-06	4.74e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.76e-06	4.71e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ERCC2—melanoma	6.74e-06	4.7e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTEN—melanoma	6.71e-06	4.67e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CD—melanoma	6.65e-06	4.63e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GNA11—melanoma	6.64e-06	4.62e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ALB—melanoma	6.57e-06	4.58e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CG—melanoma	6.54e-06	4.56e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—FASN—melanoma	6.5e-06	4.52e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC5A5—melanoma	6.39e-06	4.45e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PPARG—melanoma	6.31e-06	4.4e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ABCB1—melanoma	6.31e-06	4.4e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GNAQ—melanoma	6.17e-06	4.3e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CD44—melanoma	6.17e-06	4.3e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.13e-06	4.27e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP1B1—melanoma	5.92e-06	4.12e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CG—melanoma	5.84e-06	4.07e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PRKCA—melanoma	5.81e-06	4.05e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CB—melanoma	5.8e-06	4.04e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ERCC2—melanoma	5.76e-06	4.01e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CD—melanoma	5.75e-06	4.01e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTGS2—melanoma	5.75e-06	4e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ALB—melanoma	5.68e-06	3.95e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PPARG—melanoma	5.64e-06	3.93e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.58e-06	3.89e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CG—melanoma	5.37e-06	3.74e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CG—melanoma	5.32e-06	3.71e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PPARG—melanoma	5.18e-06	3.61e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PPARG—melanoma	5.14e-06	3.58e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CD—melanoma	5.13e-06	3.58e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ALB—melanoma	5.07e-06	3.53e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CB—melanoma	5.01e-06	3.49e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTEN—melanoma	5.01e-06	3.49e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTGS2—melanoma	4.97e-06	3.46e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CA—melanoma	4.92e-06	3.43e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ABCB1—melanoma	4.87e-06	3.39e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.77e-06	3.32e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CA—melanoma	4.73e-06	3.3e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CD—melanoma	4.72e-06	3.29e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CD—melanoma	4.68e-06	3.26e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ALB—melanoma	4.66e-06	3.25e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ALB—melanoma	4.62e-06	3.22e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CG—melanoma	4.55e-06	3.17e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PRKCA—melanoma	4.48e-06	3.12e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CB—melanoma	4.47e-06	3.12e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ERCC2—melanoma	4.45e-06	3.1e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTGS2—melanoma	4.43e-06	3.09e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PPARG—melanoma	4.39e-06	3.06e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTEN—melanoma	4.33e-06	3.02e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CB—melanoma	4.12e-06	2.87e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CB—melanoma	4.08e-06	2.84e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTGS2—melanoma	4.08e-06	2.84e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTGS2—melanoma	4.04e-06	2.82e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AKT1—melanoma	4.02e-06	2.8e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CD—melanoma	4e-06	2.79e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALB—melanoma	3.95e-06	2.75e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTEN—melanoma	3.87e-06	2.69e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AKT1—melanoma	3.86e-06	2.69e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTEN—melanoma	3.56e-06	2.48e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CA—melanoma	3.54e-06	2.46e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTEN—melanoma	3.53e-06	2.46e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CG—melanoma	3.51e-06	2.45e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CB—melanoma	3.49e-06	2.43e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTGS2—melanoma	3.45e-06	2.41e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PPARG—melanoma	3.39e-06	2.36e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CD—melanoma	3.09e-06	2.15e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CA—melanoma	3.06e-06	2.13e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALB—melanoma	3.05e-06	2.12e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTEN—melanoma	3.01e-06	2.1e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AKT1—melanoma	2.89e-06	2.01e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CA—melanoma	2.73e-06	1.9e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CB—melanoma	2.69e-06	1.87e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTGS2—melanoma	2.67e-06	1.86e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CA—melanoma	2.51e-06	1.75e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AKT1—melanoma	2.5e-06	1.74e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CA—melanoma	2.49e-06	1.73e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTEN—melanoma	2.33e-06	1.62e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AKT1—melanoma	2.23e-06	1.55e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CA—melanoma	2.13e-06	1.48e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AKT1—melanoma	2.05e-06	1.43e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AKT1—melanoma	2.03e-06	1.42e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AKT1—melanoma	1.74e-06	1.21e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CA—melanoma	1.64e-06	1.14e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AKT1—melanoma	1.34e-06	9.33e-06	CbGpPWpGaD
